2024 Q4 Form 10-Q Financial Statement
#000143774924035387 Filed on November 14, 2024
Income Statement
Concept | 2024 Q4 | 2024 Q3 |
---|---|---|
Revenue | $12.15M | |
YoY Change | 15.58% | |
Cost Of Revenue | $11.14M | |
YoY Change | 23.02% | |
Gross Profit | $1.012M | |
YoY Change | -30.64% | |
Gross Profit Margin | 8.33% | |
Selling, General & Admin | $2.329M | |
YoY Change | -12.64% | |
% of Gross Profit | 230.14% | |
Research & Development | $13.00K | |
YoY Change | -53.57% | |
% of Gross Profit | 1.28% | |
Depreciation & Amortization | $60.00K | |
YoY Change | -40.0% | |
% of Gross Profit | 5.93% | |
Operating Expenses | $2.342M | |
YoY Change | -13.07% | |
Operating Profit | -$1.658M | |
YoY Change | 16.27% | |
Interest Expense | ||
YoY Change | ||
% of Operating Profit | ||
Other Income/Expense, Net | $0.00 | |
YoY Change | -100.0% | |
Pretax Income | -$1.658M | |
YoY Change | -84.75% | |
Income Tax | $11.00K | |
% Of Pretax Income | ||
Net Earnings | -$1.669M | |
YoY Change | -84.65% | |
Net Earnings / Revenue | -13.73% | |
Basic Earnings Per Share | -$0.07 | |
Diluted Earnings Per Share | ||
COMMON SHARES | ||
Basic Shares Outstanding | 24.44M | 24.02M |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2024 Q4 | 2024 Q3 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | ||
YoY Change | ||
Cash & Equivalents | $1.355M | |
Short-Term Investments | ||
Other Short-Term Assets | ||
YoY Change | ||
Inventory | ||
Prepaid Expenses | ||
Receivables | $6.324M | |
Other Receivables | ||
Total Short-Term Assets | $8.340M | |
YoY Change | -25.21% | |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $311.0K | |
YoY Change | 31.78% | |
Goodwill | $12.04M | |
YoY Change | 0.0% | |
Intangibles | $2.146M | |
YoY Change | -23.93% | |
Long-Term Investments | ||
YoY Change | ||
Other Assets | ||
YoY Change | ||
Total Long-Term Assets | $14.78M | |
YoY Change | -14.39% | |
TOTAL ASSETS | ||
Total Short-Term Assets | $8.340M | |
Total Long-Term Assets | $14.78M | |
Total Assets | $23.12M | |
YoY Change | -18.64% | |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | ||
YoY Change | ||
Accrued Expenses | ||
YoY Change | ||
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | ||
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $7.594M | |
YoY Change | -30.18% | |
LONG-TERM LIABILITIES | ||
Long-Term Debt | ||
YoY Change | ||
Other Long-Term Liabilities | $46.00K | |
YoY Change | -82.03% | |
Total Long-Term Liabilities | $46.00K | |
YoY Change | -82.03% | |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $7.594M | |
Total Long-Term Liabilities | $46.00K | |
Total Liabilities | $7.640M | |
YoY Change | -31.37% | |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$32.60M | |
YoY Change | 25.38% | |
Common Stock | $0.00 | |
YoY Change | ||
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $15.48M | |
YoY Change | ||
Total Liabilities & Shareholders Equity | $23.12M | |
YoY Change | -18.64% |
Cashflow Statement
Concept | 2024 Q4 | 2024 Q3 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$1.669M | |
YoY Change | -84.65% | |
Depreciation, Depletion And Amortization | $60.00K | |
YoY Change | -40.0% | |
Cash From Operating Activities | ||
YoY Change | ||
INVESTING ACTIVITIES | ||
Capital Expenditures | ||
YoY Change | ||
Acquisitions | ||
YoY Change | ||
Other Investing Activities | ||
YoY Change | ||
Cash From Investing Activities | ||
YoY Change | ||
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | ||
YoY Change | ||
NET CHANGE | ||
Cash From Operating Activities | ||
Cash From Investing Activities | ||
Cash From Financing Activities | ||
Net Change In Cash | ||
YoY Change | ||
FREE CASH FLOW | ||
Cash From Operating Activities | ||
Capital Expenditures | ||
Free Cash Flow | ||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001940177 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
PodcastOne, Inc. | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--03-31 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q2 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2025 | ||
CY2024Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2024Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2024Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.00001 | |
CY2024Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.00001 | |
CY2024Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | |
CY2024Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | |
CY2024Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
24404187 | |
CY2024Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
24404187 | |
CY2024Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
23608049 | |
CY2024Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
23608049 | |
CY2024Q3 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | usd |
us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | usd | |
us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | usd | |
us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
0 | usd | |
CY2023Q3 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
0 | usd |
CY2024Q3 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
0 | usd |
CY2024Q3 | us-gaap |
Number Of Reporting Units
NumberOfReportingUnits
|
1 | pure |
us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
0 | usd | |
CY2024Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
0 | usd |
CY2023Q3 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
0 | usd |
CY2024Q3 | ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false | |
CY2024Q3 | ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false | |
CY2024Q3 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false | |
CY2024Q3 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false | |
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2024-09-30 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
001-41795 | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
35-2503373 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
345 North Maple Drive, Suite 295 | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Beverly Hills | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
CA | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
90212 | ||
dei |
City Area Code
CityAreaCode
|
310 | ||
dei |
Local Phone Number
LocalPhoneNumber
|
858-0888 | ||
dei |
Security12b Title
Security12bTitle
|
Common stock, $0.00001 par value per share | ||
dei |
Trading Symbol
TradingSymbol
|
PODC | ||
dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | ||
dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
CY2024Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
24438160 | |
CY2024Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1355000 | usd |
CY2024Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1445000 | usd |
CY2024Q3 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
6324000 | usd |
CY2024Q1 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
6023000 | usd |
CY2024Q3 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
661000 | usd |
CY2024Q1 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
1105000 | usd |
CY2024Q3 | us-gaap |
Assets Current
AssetsCurrent
|
8340000 | usd |
CY2024Q1 | us-gaap |
Assets Current
AssetsCurrent
|
8573000 | usd |
CY2024Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
311000 | usd |
CY2024Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
309000 | usd |
CY2024Q3 | us-gaap |
Goodwill
Goodwill
|
12041000 | usd |
CY2024Q1 | us-gaap |
Goodwill
Goodwill
|
12041000 | usd |
CY2024Q3 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
2146000 | usd |
CY2024Q1 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
3145000 | usd |
CY2024Q3 | us-gaap |
Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
|
281000 | usd |
CY2024Q1 | us-gaap |
Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
|
57000 | usd |
CY2024Q3 | us-gaap |
Assets
Assets
|
23119000 | usd |
CY2024Q1 | us-gaap |
Assets
Assets
|
24125000 | usd |
CY2024Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
7594000 | usd |
CY2024Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
7698000 | usd |
CY2024Q3 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
46000 | usd |
CY2024Q1 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
86000 | usd |
CY2024Q3 | us-gaap |
Liabilities
Liabilities
|
7640000 | usd |
CY2024Q1 | us-gaap |
Liabilities
Liabilities
|
7784000 | usd |
CY2024Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
0 | usd |
CY2024Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
0 | usd |
CY2024Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
48125000 | usd |
CY2024Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
45952000 | usd |
CY2024Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-32646000 | usd |
CY2024Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-29611000 | usd |
CY2024Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
15479000 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
16341000 | usd |
CY2024Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
23119000 | usd |
CY2024Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
24125000 | usd |
CY2024Q3 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
12154000 | usd |
CY2023Q3 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
10516000 | usd |
us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
25312000 | usd | |
us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
21153000 | usd | |
CY2024Q3 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
11142000 | usd |
CY2023Q3 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
9057000 | usd |
us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
22851000 | usd | |
us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
17279000 | usd | |
CY2024Q3 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
877000 | usd |
CY2023Q3 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
1451000 | usd |
us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
1724000 | usd | |
us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
2701000 | usd | |
CY2024Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
13000 | usd |
CY2023Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
28000 | usd |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
31000 | usd | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
55000 | usd | |
CY2024Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1452000 | usd |
CY2023Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1215000 | usd |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2849000 | usd | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2135000 | usd | |
CY2024Q3 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
0 | usd |
CY2023Q3 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
0 | usd |
us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
176000 | usd | |
us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
0 | usd | |
CY2024Q3 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
328000 | usd |
CY2023Q3 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
191000 | usd |
us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
705000 | usd | |
us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
216000 | usd | |
CY2024Q3 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
13812000 | usd |
CY2023Q3 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
11942000 | usd |
us-gaap |
Costs And Expenses
CostsAndExpenses
|
28336000 | usd | |
us-gaap |
Costs And Expenses
CostsAndExpenses
|
22386000 | usd | |
CY2024Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1658000 | usd |
CY2023Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1426000 | usd |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3024000 | usd | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1233000 | usd | |
CY2024Q3 | us-gaap |
Interest Expense Nonoperating
InterestExpenseNonoperating
|
-0 | usd |
CY2023Q3 | us-gaap |
Interest Expense Nonoperating
InterestExpenseNonoperating
|
654000 | usd |
us-gaap |
Interest Expense Nonoperating
InterestExpenseNonoperating
|
-0 | usd | |
us-gaap |
Interest Expense Nonoperating
InterestExpenseNonoperating
|
2247000 | usd | |
CY2024Q3 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-0 | usd |
CY2023Q3 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
8793000 | usd |
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-0 | usd | |
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
7603000 | usd | |
CY2024Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
0 | usd |
CY2023Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-9447000 | usd |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
0 | usd | |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-9850000 | usd | |
CY2024Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-1658000 | usd |
CY2023Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-10873000 | usd |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-3024000 | usd | |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-11083000 | usd | |
CY2024Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
11000 | usd |
CY2023Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | usd |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
11000 | usd | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | usd | |
CY2024Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1669000 | usd |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-10873000 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-3035000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-11083000 | usd | |
CY2024Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.07 | |
CY2023Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.52 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.13 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.54 | ||
CY2024Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
24162612 | |
CY2023Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
20714161 | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
23991772 | ||
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
20357080 | ||
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
16341000 | usd |
CY2024Q2 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
220000 | usd |
CY2024Q2 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
0 | usd |
CY2024Q2 | us-gaap |
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
|
174000 | usd |
CY2024Q2 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
305000 | usd |
CY2024Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1366000 | usd |
CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
15674000 | usd |
CY2024Q3 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
600000 | usd |
CY2024Q3 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
0 | usd |
CY2024Q3 | us-gaap |
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
|
736000 | usd |
CY2024Q3 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
138000 | usd |
CY2024Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1669000 | usd |
CY2024Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
15479000 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
7119000 | usd |
CY2023Q2 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
84000 | usd |
CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-210000 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
6993000 | usd |
CY2023Q3 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
842000 | usd |
CY2023Q3 | podc |
Adjustments To Additional Paid In Capital Common Stock Warrants Reclassified To Equity
AdjustmentsToAdditionalPaidInCapitalCommonStockWarrantsReclassifiedToEquity
|
9116000 | usd |
CY2023Q3 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
10276000 | usd |
CY2023Q3 | us-gaap |
Dividends Common Stock
DividendsCommonStock
|
-0 | usd |
CY2023Q3 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
12000 | usd |
CY2023Q3 | podc |
Stock Issued During Period Value Purchase Of Intangibles
StockIssuedDuringPeriodValuePurchaseOfIntangibles
|
917000 | usd |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-10873000 | usd |
CY2023Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
17283000 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-3035000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-11083000 | usd | |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
837000 | usd | |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
338000 | usd | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1263000 | usd | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
938000 | usd | |
us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
0 | usd | |
us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
1949000 | usd | |
podc |
Change In Fair Value Of Bifurcated Embedded Derivatives
ChangeInFairValueOfBifurcatedEmbeddedDerivatives
|
0 | usd | |
podc |
Change In Fair Value Of Bifurcated Embedded Derivatives
ChangeInFairValueOfBifurcatedEmbeddedDerivatives
|
7603000 | usd | |
us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
176000 | usd | |
us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
0 | usd | |
us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
-5000 | usd | |
us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
92000 | usd | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
296000 | usd | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
2909000 | usd | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-444000 | usd | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-39000 | usd | |
us-gaap |
Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
|
1305000 | usd | |
us-gaap |
Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
|
2071000 | usd | |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-644000 | usd | |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
1287000 | usd | |
us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
0 | usd | |
us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
256000 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
45000 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
581000 | usd | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
135000 | usd | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
116000 | usd | |
us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
-0 | usd | |
us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
536000 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-135000 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-652000 | usd | |
us-gaap |
Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
|
-0 | usd | |
us-gaap |
Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
|
3000000 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
0 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-3000000 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-90000 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-3071000 | usd | |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
1445000 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
3562000 | usd |
CY2024Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
1355000 | usd |
CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
491000 | usd |
us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | usd | |
us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | usd | |
us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | usd | |
us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | usd | |
podc |
Stock Accrued To Repay
StockAccruedToRepay
|
910000 | usd | |
podc |
Stock Accrued To Repay
StockAccruedToRepay
|
0 | usd | |
podc |
Accrued Expenses Written Off Associated With Intangible Asset Impairment
AccruedExpensesWrittenOffAssociatedWithIntangibleAssetImpairment
|
118000 | usd | |
podc |
Accrued Expenses Written Off Associated With Intangible Asset Impairment
AccruedExpensesWrittenOffAssociatedWithIntangibleAssetImpairment
|
0 | usd | |
CY2024Q3 | us-gaap |
Assets Net
AssetsNet
|
16100000 | usd |
CY2024Q3 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
1400000 | usd |
CY2024Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-32600000 | usd |
CY2024Q3 | podc |
Working Capital
WorkingCapital
|
700000 | usd |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i><span style="text-decoration: underline; ">Use of Estimates</span></i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The preparation of the Company’s interim unaudited condensed consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Significant items subject to such estimates and assumptions include revenue, allowance for doubtful accounts, the assigned value of acquired assets and assumed and contingent liabilities associated with business combinations and the related purchase price allocation, useful lives and impairment of property and equipment, intangible assets, goodwill and other assets, the fair value of the Company’s equity-based compensation awards and convertible debt and debt instruments, fair values of derivatives, and contingencies.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Actual results could differ materially from those estimates. On an ongoing basis, the Company evaluates its estimates compared to historical experience and trends, which form the basis for making judgments about the carrying value of assets and liabilities. </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"></p> | ||
us-gaap |
Advertising Expense
AdvertisingExpense
|
100000 | usd | |
us-gaap |
Advertising Expense
AdvertisingExpense
|
100000 | usd | |
CY2024Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1355000 | usd |
CY2023Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
491000 | usd |
CY2024Q3 | us-gaap |
Accounts Receivable Gross
AccountsReceivableGross
|
6396000 | usd |
CY2024Q1 | us-gaap |
Accounts Receivable Gross
AccountsReceivableGross
|
6099000 | usd |
CY2024Q3 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
72000 | usd |
CY2024Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
76000 | usd |
CY2024Q3 | us-gaap |
Accounts Receivable Net
AccountsReceivableNet
|
6324000 | usd |
CY2024Q1 | us-gaap |
Accounts Receivable Net
AccountsReceivableNet
|
6023000 | usd |
CY2023Q3 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | usd |
us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
200000 | usd | |
us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i><span style="text-decoration: underline; ">Concentration of Credit Risk</span></i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company maintains cash balances at commercial banks. Cash balances commonly exceed the $250,000 amount insured by the Federal Deposit Insurance Corporation. The Company has <em style="font: inherit;">not</em> experienced any losses in such accounts, and management believes that the Company is <em style="font: inherit;">not</em> exposed to any significant credit risk with respect to such cash and cash equivalents.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"></p> | ||
CY2024Q3 | us-gaap |
Cash Fdic Insured Amount
CashFDICInsuredAmount
|
250000 | usd |
CY2024Q3 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
1157000 | usd |
CY2024Q1 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
1024000 | usd |
CY2024Q3 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
846000 | usd |
CY2024Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
715000 | usd |
CY2024Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
311000 | usd |
CY2024Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
309000 | usd |
CY2024Q3 | us-gaap |
Depreciation
Depreciation
|
60000.00 | usd |
CY2023Q3 | us-gaap |
Depreciation
Depreciation
|
70000.00 | usd |
us-gaap |
Depreciation
Depreciation
|
100000 | usd | |
us-gaap |
Depreciation
Depreciation
|
100000 | usd | |
CY2024Q1 | us-gaap |
Goodwill
Goodwill
|
12041000 | usd |
us-gaap |
Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
|
0 | usd | |
CY2024Q3 | us-gaap |
Goodwill
Goodwill
|
12041000 | usd |
CY2024Q3 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
4699000 | usd |
CY2024Q3 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
2553000 | usd |
CY2024Q3 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
2146000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
5092000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
1947000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
3145000 | usd |
us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
200000 | usd | |
CY2024Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
|
564000 | usd |
CY2024Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
915000 | usd |
CY2024Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
338000 | usd |
CY2024Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
109000 | usd |
CY2024Q3 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
101000 | usd |
CY2024Q3 | podc |
Finitelived Intangible Asset Expected Amortization After Year Four
FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour
|
119000 | usd |
CY2024Q3 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
2146000 | usd |
CY2024Q3 | us-gaap |
Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
|
785000 | usd |
CY2024Q1 | us-gaap |
Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
|
1529000 | usd |
CY2024Q3 | podc |
Accrued Revenue Share
AccruedRevenueShare
|
3451000 | usd |
CY2024Q1 | podc |
Accrued Revenue Share
AccruedRevenueShare
|
2945000 | usd |
CY2024Q3 | us-gaap |
Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
|
2422000 | usd |
CY2024Q1 | us-gaap |
Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
|
2909000 | usd |
CY2024Q3 | us-gaap |
Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
|
6658000 | usd |
CY2024Q1 | us-gaap |
Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
|
7383000 | usd |
CY2023Q4 | podc |
Warrants Embedded Redemption Liability Derivative And Fees
WarrantsEmbeddedRedemptionLiabilityDerivativeAndFees
|
5800000 | usd |
us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
1200000 | usd | |
CY2024Q3 | us-gaap |
Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
|
2600000 | usd |
CY2024Q3 | us-gaap |
Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
|
600000 | usd |
CY2024Q3 | us-gaap |
Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
|
500000 | usd |
CY2024Q3 | us-gaap |
Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
|
500000 | usd |
CY2022Q4 | us-gaap |
Line Of Credit Facility Fair Value Of Amount Outstanding
LineOfCreditFacilityFairValueOfAmountOutstanding
|
7000000 | usd |
CY2022Q4 | us-gaap |
Litigation Settlement Amount Awarded To Other Party
LitigationSettlementAmountAwardedToOtherParty
|
9800000 | usd |
CY2024Q3 | us-gaap |
Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Rate Of Compensation Increase
DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
|
1 | pure |
CY2024Q3 | us-gaap |
Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase
DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
|
0.05 | pure |
CY2024Q3 | podc |
Common Stock Shares Cancelled
CommonStockSharesCancelled
|
127984230 | |
CY2022Q4 | us-gaap |
Excess Stock Shares Authorized
ExcessStockSharesAuthorized
|
110000000 | |
CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.00001 | |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
140000 | |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
1.87 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
0 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
0 | ||
us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
-0 | ||
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
15000 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
4.2 | ||
CY2024Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
125000 | |
CY2024Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
1.59 | |
CY2024Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
115000 | |
CY2024Q3 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
|
1.31 | |
CY2024Q3 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P7Y3M14D | |
CY2023Q3 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P7Y4M2D | |
CY2024Q3 | podc |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingFairValue
|
200000 | usd |
CY2024Q3 | podc |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableFairValue
|
200000 | usd |
CY2023Q3 | podc |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingFairValue
|
300000 | usd |
CY2023Q3 | podc |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableFairValue
|
100000 | usd |
CY2024Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
|
110000000 |